Personalized treatment help 19-yr-old defeat blood cancer

6 122
Dr. N Aditya Murali, Consultant, Aster CMI Hospital, Bengaluru

 DTMT Network
BANGALORE : Suffering from a rare form of blood cancer, 19-year-old Roopa was able to beat all odds and tackle life with zest after receiving complete remission, states a press release by Aster CMI Hospital, Bengaluru.

The patient being a young lady, the doctors in the hospital decided to give her a personalized treatment which not only cured her cancer but also enabled her to manage her academics efficiently. She was then planned to undergo a chemotherapy - free regimen where only targeted medications were used to bring her cancer under control, the release said.

After 6 weeks, the patient's bone marrow test was repeated showing the cancer to be in complete remission. Roopa needed four more months of consolidation therapy. However, this did not deter her from resuming her academic career. Today she attends college five days a week and comes to the hospital in the evening to continue her treatment.

“Since she required daily injections for alternate months, we worked out a schedule for her where she could come to the hospital in the morning, give her blood sample for testing, go to college and come late in the afternoon by which time the reports were ready and she could receive the day's treatment as per protocol. The use of targeted agents helped minimize the side effects and ensured that day to day life did not get affected,” said Dr. N Aditya Murali, Consultant, Medical and Hemato-Oncology.

“Cancer must be looked at as any other disease and patients must approach the treatment with a positive attitude,” said Dr. Vijay Agarwal, Sr. Consultant Medical Oncology & Hematology.

Roopa was suffering from Acute Pro-Myelocytic Leukaemia, a disease which is usually seen in people 40-50 years of age and is very rarely found among individuals below the age of 20.

The disease is quite fatal early on and during the initial few weeks of diagnosis the risk of internal bleeding is quite high.


  1. Be first to post your comments

Your Comment

Your email address will not be published. Required fields are marked *


Back to Top